SINOBIO19.BK Sino Biopharmaceutical Limited

Healthcare Biotechnology Thailand Exchange
4.80 THB
Close of Nov 7, 2026
3.55 5.37
Market cap
THB 85.4B
P/E
7.9x
P/B
0.52x
ROE
7.6%
Dividend yield
2.43%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is SINOBIO19.BK undervalued?

Graham number
Price4.80
Graham value11.25
Discount57.3%

SINOBIO19.BK trades 57.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sino Biopharmaceutical Limited fundamental analysis

No fundamental analysis for Sino Biopharmaceutical Limited yet.

Sino Biopharmaceutical Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, ben…

Full company profile